Aristides Capital’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Sell
37,212
-37,036
-50% -$1.53M 0.3% 66
2025
Q4
$3.47M Buy
74,248
+17,670
+31% +$764K 0.61% 34
2025
Q3
$2.37M Buy
56,578
+19,000
+51% +$835K 0.34% 50
2025
Q2
$1.65M Sell
37,578
-26,412
-41% -$1.2M 0.33% 51
2025
Q1
$3.22M Sell
63,990
-18,143
-22% -$900K 0.95% 28
2024
Q4
$3.53M Buy
82,133
+14,641
+22% +$618K 0.72% 23
2024
Q3
$2.65M Buy
67,492
+7,492
+12% +$271K 0.82% 29
2024
Q2
$1.93M Buy
+60,000
New +$1.94M 0.55% 33

Other funds holding G

Aristides Capital's G Position: Q1 2026 in Review

Aristides Capital reduced its Genpact (G) stake by 50% in Q1 2026, selling an estimated $1.53M and leaving 37,212 shares worth $1.39M. The position accounts for 0.3% of the portfolio, ranked #66.

Aristides Capital first reported a position in G in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.53M in Q4 2024. 515 funds tracked by Wall St. Rank hold G as of Q1 2026.

  • Aristides Capital held 37,212 shares of Genpact worth $1.39M as of Q1 2026.
  • Aristides Capital sold 37,036 Genpact shares in Q1 2026, an estimated $1.53M.
  • Genpact made up 0.3% of Aristides Capital's portfolio in Q1 2026, its #66 holding.
  • Aristides Capital first reported a position in Genpact in Q2 2024 and has held it in 8 quarters since.
  • Aristides Capital's Genpact position peaked at $3.53M in Q4 2024.
  • 515 funds tracked by Wall St. Rank held Genpact as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.